Practice 9 structured short- and long-answer medical questions on Disorders of the Vagina and Breast. Review model answers for exam revision.
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: This content details various disorders affecting the vagina and the breast, including both benign and malignant conditions. For the vagina, common issues like vaginitis caused by infections (Trichomonas, Candida, bacterial vaginosis, STIs) and atrophic changes are discussed, alongside rare but significant malignancies such as squamous cell carcinoma, clear cell adenocarcinoma (linked to DES exposure), and sarcoma botryoides (a pediatric tumor). The breast section covers fibrocystic changes with varying risks of carcinoma, inflammatory processes like mastitis and fat necrosis, and a range of breast tumors including fibroadenomas, phyllodes tumors, intraductal papillomas, and various forms of carcinoma (in situ and invasive). Special attention is given to the molecular subtypes of breast cancer, inflammatory breast cancer, prognostic factors, and common lesions in the male breast, such as gynecomastia and carcinoma. ## Key Points - **Vaginitis:** Common condition characterized by discharge, itching, or burning, with key infectious causes including *Trichomonas vaginalis*, *Candida albicans*, and *Gardnerella vaginalis* (bacterial vaginosis). - **Clear Cell Adenocarcinoma of the Vagina:** Strongly associated with in utero exposure to diethylstilbestrol (DES). - **Sarcoma Botryoides:** The most common malignant vaginal tumor in infants and young girls under 5 years. - **Fibrocystic Changes:** A spectrum of benign breast changes driven by hormonal fluctuations, categorized into nonproliferative, proliferative, and atypical hyperplasia, with increasing risk of carcinoma correlating with atypia. - **Invasive Ductal Carcinoma (IDC) - NST:** The most common type of invasive breast cancer, characterized by a firm, gritty mass and desmoplastic stromal reaction. - **Invasive Lobular Carcinoma (ILC):** Characterized by loss of E-cadherin, leading to single-file infiltration and often bilateral/multicentric presentation. - **Molecular Subtypes of Breast Cancer:** Categorized by ER/PR and HER2 status (Luminal A, Luminal B, HER2-enriched, Triple-negative), impacting prognosis and treatment. - **Gynecomastia:** Enlargement of the male breast due to an imbalance between estrogen and androgen activity. - **Male Breast Carcinoma:** Rare, but almost always ER and PR positive, with a prognosis similar to female breast cancer at the same stage. ## Detailed Notes ## 6. Disorders of the Vagina **Conditions covered:** Vaginitis · Squamous Cell Carcinoma · Clear Cell Adenocarcinoma · Sarcoma Botryoides ### Vaginitis **Key causes:** Infections · Atrophic changes · Chemical irritation Vaginitis is extremely common and often presents with vaginal discharge, itching, and burning. **Important infectious causes:** - **Trichomonas vaginalis:** A flagellated protozoan, sexually transmitted. Characterized by frothy, yellow-green discharge and a "strawberry cervix" on examination. - **Candida albicans:** Causes thick, white, cottage-cheese-like discharge with intense pruritus. Common in diabetics, pregnant women, antibiotic users, and the immunocompromised. - **Gardnerella vaginalis (Bacterial vaginosis):** Results in a thin, grey-white, fishy-smelling discharge. It's not strictly an STI but an overgrowth of anaerobes replacing normal lactobacilli. Clue cells (epithelial cells studded with bacteria) are seen on microscopy. - **N. gonorrhoeae / C. trachomatis:** Can cause ascending infections involving the upper genital tract. - **HSV-2:** Presents with painful vesicular ulcers. **Atrophic vaginitis:** Occurs postmenopausally due to loss of estrogen, leading to a thin, dry epithelium that is prone to inflammation and bleeding. **Key point:** The normal vaginal flora is dominated by lactobacilli, which maintain an acidic pH. Disruption of this balance predisposes to infection. --- ### Malignant Neoplasms of the Vagina **Conditions covered:** Squamous Cell Carcinoma · Clear Cell Adenocarcinoma · Sarcoma Botryoides #### Squamous Cell Carcinoma Primary vaginal squamous cell carcinoma (SCC) is **rare**; most vaginal malignancies are secondary metastases. It occurs mostly in women over 60 years. **HPV** (types 16 and 18) plays a role, similar to cervical SCC. It is preceded by **vaginal intraepithelial neoplasia (VAIN)**. - **Location:** Most commonly in the upper posterior vaginal wall. - **Presentation:** Vaginal bleeding, discharge, dyspareunia. - **Spread:** Direct extension to the bladder, rectum, and pelvic sidewall; lymph node metastasis. - **Prognosis:** Generally poor due to late presentation. #### Clear Cell Adenocarcinoma This is **strongly associated with in utero exposure to diethylstilbestrol (DES)**. It develops in young women (teens to early 20s) whose mothers took DES during pregnancy. DES exposure causes **vaginal adenosis**, which is the persistence of glandular epithelium in the vagina. - **Histology:** Characterized by clear cells with hobnail nuclei protruding into glandular lumina. - **Location:** Usually the anterior wall of the upper vagina. - **Key point:** This tumor is now historically rare but important for examination purposes. #### Sarcoma Botryoides (Embryonal Rhabdomyosarcoma) This is the **most common malignant vaginal tumor in infants and young girls under 5 years**. It arises from embryonal rhabdomyoblasts beneath the vaginal epithelium. - **Gross appearance:** Soft, grape-like polypoid masses protruding from the vagina. - **Histology:** Small primitive cells with occasional large strap cells (rhabdomyoblasts) showing cross-striations; a characteristic **cambium layer** (dense subepithelial condensation of tumor cells) is present. - **Presentation:** Vaginal mass or bleeding in a young child. - **Behaviour:** Highly aggressive, invading locally and metastasizing widely. - **Treatment:** Combined surgery, chemotherapy, and radiation. --- ## 7. Disorders of the Breast **Conditions covered:** Fibrocystic Changes · Inflammatory Processes · Tumours (Fibroadenoma · Phyllodes Tumour · Intraductal Papilloma · Carcinoma) · Lesions of the Male Breast --- ### Fibrocystic Changes **Conditions covered:** Nonproliferative Changes · Proliferative Changes · Relationship to Carcinoma Fibrocystic changes are the most common breast disorder, affecting women of reproductive age. It's a broad term encompassing morphologic changes driven by hormonal fluctuations. Presentation is often as breast lumps, tenderness, or nodularity that fluctuates with the menstrual cycle. #### Nonproliferative Changes These changes carry **no increased risk of carcinoma**. - **Cyst formation:** Fluid-filled cysts lined by flattened or apocrine metaplastic epithelium. Appear as "blue-dome cysts" on gross examination. - **Apocrine metaplasia:** Benign lining cells resembling apocrine sweat gland cells. - **Mild epithelial hyperplasia:** A slight increase in cell layers lining ducts, without atypia. - **Stromal fibrosis:** Increase in fibrous stroma, giving the breast a firm, rubbery texture. #### Proliferative Changes These carry a slightly to significantly increased risk of carcinoma. - **Moderate to florid epithelial hyperplasia (without atypia):** Slightly increased risk (~1.5–2x) of carcinoma. - **Sclerosing adenosis:** Increased acini per lobule with stromal fibrosis; can mimic carcinoma but is benign. - **Atypical hyperplasia (ductal or lobular):** Significant increased risk (~4–5x) of carcinoma. - **Atypical ductal hyperplasia (ADH):** Partial involvement of ducts by cells resembling DCIS. - **Atypical lobular hyperplasia (ALH):** Partial involvement of lobules by cells resembling LCIS. #### Relationship of Fibrocystic Changes to Breast Carcinoma | Type | Relative Risk of Carcinoma | | :------------------------------------- | :------------------------- | | Nonproliferative changes | No increased risk | | Proliferative changes without atypia | 1.5–2x increased risk | | Atypical hyperplasia (ADH or ALH) | 4–5x increased risk | | Atypical hyperplasia + family history of breast cancer | 10x increased risk | **Key point:** The risk is bilateral, applying to both breasts. --- ### Inflammatory Processes of the Breast **Conditions covered:** Acute Mastitis · Fat Necrosis · Mammary Duct Ectasia #### Acute Mastitis Almost exclusively occurs during **lactation**. Most commonly caused by **S. aureus**, entering via nipple fissures. Presents as a painful, red, swollen breast with fever, and may progress to abscess. Treatment includes antibiotics and, if necessary, surgical drainage. Breastfeeding should continue if possible. #### Fat Necrosis Follows **trauma or surgery** to the breast. It presents as a firm, sometimes calcified mass that can **mimic carcinoma**. Histologically, it shows necrotic fat cells surrounded by inflammatory cells and fibrosis. It is **benign**. #### Mammary Duct Ectasia Dilation of major ducts with thickened secretions and inflammation, occurring in **perimenopausal and postmenopausal women**. Presents with thick, white/greenish nipple discharge, a subareolar mass, and skin retraction, mimicking carcinoma. Histologically, dilated ducts are seen with inflammatory changes. It is **benign** but clinically important. --- ### Tumours of the Breast **Conditions covered:** Fibroadenoma · Phyllodes Tumour · Intraductal Papilloma · Carcinoma #### Fibroadenoma The **most common benign tumour of the breast**, most frequent in women under 30. It is a biphasic tumor of stroma and epithelium. Grossly, it is a well-circumscribed, firm, rubbery, mobile mass ("breast mouse"). Histologically, it shows a loose stroma surrounding duct-like spaces. It is estrogen-sensitive and has **no significant malignant potential**. #### Phyllodes Tumour Similar to fibroadenoma but with **more cellular stroma and a leaf-like architecture**. Occurs in older women (40s–50s). It has a **spectrum from benign to malignant**. Malignant phyllodes tumours can metastasize hematogenously. Treatment is wide local excision. #### Intraductal Papilloma A benign papillary growth within a **lactiferous duct**, usually near the nipple. Most common in women **35–55 years**. The classic presentation is **unilateral bloody or serous nipple discharge**. Solitary papillomas have low malignant risk, while multiple peripheral papillomas have a higher risk. Histologically, they have fibrovascular cores lined by epithelial and myoepithelial cells (presence of myoepithelial cells confirms benignity). Treatment is surgical excision. #### Carcinoma of the Breast The most common malignancy in women. **Risk factors** include female sex, increasing age, family history, BRCA1/BRCA2 mutations, hormonal factors, and prior breast biopsy with atypical hyperplasia. ##### BRCA1 and BRCA2 Tumor suppressor genes involved in DNA repair. BRCA1 carriers have a ~60-80% lifetime risk of breast cancer; BRCA2 carriers have a ~40-70% risk. Both also increase ovarian cancer risk. BRCA1-associated cancers are often ER-negative, high-grade, and triple-negative. ##### In Situ Carcinomas - **Ductal Carcinoma In Situ (DCIS):** Malignant cells confined within ducts. Detected by mammography (microcalcifications). The **comedo type** is high-grade and most aggressive. If untreated, it has a significant risk of progressing to invasive carcinoma. Treatment is surgical excision ± radiation ± tamoxifen. - **Lobular Carcinoma In Situ (LCIS):** Malignant cells filling lobular acini. Often an incidental finding, it is a **marker of increased risk** for invasive carcinoma in **both breasts**. Associated with loss of **E-cadherin** expression. Treatment is observation with surveillance or bilateral prophylactic mastectomy in high-risk cases. ##### Invasive (Infiltrating) Carcinomas - **Invasive Ductal Carcinoma (IDC) — No Special Type (NST):** Most common type (~70–80%). Presents as a firm, gritty, stellate mass. Spreads to **axillary lymph nodes**, which are the most important prognostic factor. Graded I–III. - **Invasive Lobular Carcinoma (ILC):** ~10–15% of invasive cancers. Characterized by loss of **E-cadherin**, leading to infiltration in single file ("Indian file pattern"). Often **bilateral and multicentric**, and can be difficult to detect. Tends to metastasize to unusual sites. - **Special Types (better prognosis):** Tubular carcinoma, mucinous (colloid) carcinoma, medullary carcinoma. ##### Molecular Subtypes of Breast Cancer | Subtype | ER/PR | HER2 | Features | | :--------------- | :-------- | :------ | :------------------------------------------- | | Luminal A | Positive | Negative | Best prognosis; hormone therapy | | Luminal B | Positive | Positive or negative | Intermediate prognosis | | HER2-enriched | Negative | Positive | Aggressive; targeted therapy (trastuzumab) | | Triple-negative | Negative | Negative | Worst prognosis; associated with BRCA1 | ##### Inflammatory Breast Carcinoma An aggressive clinical presentation mimicking acute mastitis, caused by **tumour emboli blocking dermal lymphatics**. Characterized by peau d'orange appearance. Very poor prognosis. ##### Clinical Features and Spread Presents as a painless lump, nipple discharge, or skin changes. Spreads to **axillary lymph nodes**, then internal mammary and supraclavicular nodes. Distant metastases commonly occur in bone, lung, liver, brain, and adrenal glands. **Sentinel lymph node biopsy** is used for staging. ##### Prognostic Factors The most important prognostic factor is **lymph node status**. Other factors include tumor size, histologic grade, hormone receptor status, HER2 status, and molecular subtype. --- ### Lesions of the Male Breast **Conditions covered:** Gynecomastia · Carcinoma #### Gynecomastia **Enlargement of the male breast** due to an **imbalance between oestrogen and androgen activity**. Causes include physiological changes (neonates, puberty, elderly), liver disease, Klinefelter syndrome, estrogen-secreting tumors, and certain drugs (e.g., spironolactone, digoxin). Histologically, it shows ductal epithelial hyperplasia with periductal oedematous stroma. It is **not premalignant**. #### Male Breast Carcinoma Rare, accounting for ~1% of all breast cancers. **Risk factors** include Klinefelter syndrome, BRCA2 mutations, exogenous estrogens, and liver disease. Most are **invasive ductal carcinoma** and almost always **ER and PR positive**. Presents as a subareolar mass. Prognosis is stage-for-stage similar to female breast cancer, but often diagnosed later. Treatment includes mastectomy and hormone therapy. --- ## Practice Questions